Results 101 to 110 of about 230,556 (169)

Performance of apparent diffusion coefficient of medial and lateral rectus muscles in Graves' orbitopathy

, 2017
Objective The purpose of this study was to determine the performance of the apparent diffusion coefficient in the detection of involvement of the medial and lateral rectus muscles in patients with Graves' orbitopathy.
Mohamed E Moawad, Nader El-Metwaly, Amr A El-Said, Mohamed El-Hadidy, Ahmed AK Abdel Razek   +4 more
core   +1 more source

Steroid Treatment Focused Management of Graves’ Ophthalmopathy

Acta Medica Bulgarica
Graves' disease (GD) is an autoimmune disease that affects the thyroid and the eyes. Graves' ophthalmopathy (GO), an autoimmune disease, usually appears 18 months after GD diagnosis.
Condeng Y. H., Umar H., Aman A. M., Rasyid H., Bakri S., Iskandar H.   +5 more
doaj   +1 more source

Association between lipid profiles and Graves orbitopathy: A systematic review and meta analysis

Endocrine and Metabolic Science
Introduction: Graves orbitopathy (GO) is an autoimmune disorder affecting the tissues around the eyes, seen in 25–50 % of individuals with Graves disease (GD).
Nanny Natalia Mulyani Soetedjo, Louis Fabio Jonathan Jusni, Eric Ricardo Yonatan, Steven Alvianto, Nicolas Daniel Widjanarko, Hikmat Permana   +5 more
doaj   +1 more source

Clinical characteristics of Graves’ orbitopathy [PDF]

, 2014
State Medical and Pharmaceutical University “Nicolae Testemitanu”, Chisinau, Republic of MoldovaIntroduction: Graves’ orbitopathy (GO) constitutes a major clinical and therapeutic challenge. GO is an autoimmune disorder representing the most common and
Iacob, Sergiu
core   +1 more source

Anatomy-based surgical concepts for individualized orbital decompression surgery in graves orbitopathy. I. Orbital size and geometry

, 2010
To analyze orbital morphological parameters that potentially could influence the effect of decompression surgery on exophthalmos reduction in Graves orbitopathy, thus making decompression surgery more ...
Lukas Kamer, Alexander Schramm, Beat Hammer, Noser, Hansrudi, Hansrudi Noser, Schramm, Alexander, Kirsch, Eberhard, Hammer, Beat, Eberhard Kirsch, Kamer, Lukas, Hammer B, Noser H, Schramm A, Kamer L, Kirsch E   +14 more
core   +1 more source

Surgical treatment of globe subluxation in the active phase of the myogenic type of Graves orbitopathy: case reports

, 2012
The purpose of the present article is to present and discuss two cases of globe subluxation in the active phase of myogenic Graves' orbitopathy and to evaluate the prevalence of this phenomenon.
Eing, Felipe, Velasco e Cruz, Antonio Augusto   +1 more
core   +1 more source

Active Thyroid Orbitopathy in a Colombian Population. Characteristics Associated With its Response to Steroids

Clinical Medicine Insights: Endocrinology and Diabetes
Objective A significant proportion of patients with Graves’ orbitopathy do not respond adequately to treatment with glucocorticoids. Early identification of clinical factors associated with therapeutic response may help optimize management.
Jhoán Gutiérrez-Palma, Darío Parra-Prieto, Claudia Gómez-Giraldo, Jennifer Camargo-González, Luisa González-Serna, Luis Rodríguez-Hortua, Manuela Quiñonez-Rodríguez, Juan Camilo García, Óscar Muñoz-Velandia   +8 more
doaj   +1 more source

Graves’ Orbitopathy

International Journal of Endocrinology, 2015
Yuji Hiromatsu, Jack R. Wall, George J. Kahaly, Hirohiko Kakizaki   +3 more
doaj   +1 more source

Optics Neuropathy in Graves\u27 Orbitopathy: Are Visual Evoked Potential A Useful Test?

, 2008
The aim of the study is to determine the accuracy of the pattern visual evoked potential (P-YEP), compared to the clinical tests, for an early detection of optic neuropathy in Graves\u27 ...
Anconella Boschi; Marianne de Tourtchaninoff; Chantal Daumerie
core  

Liraglutide reduces lipid accumulation in human orbital fibroblasts in Graves' orbitopathy. [PDF]

Front Endocrinol (Lausanne)
Shih CW, Shih SR, Wei YH, Lin CH, Liao SL, Chou TA, Chu I, Chen HJ, Liao NL, Tsai FC.   +9 more
europepmc   +1 more source